A spontaneous breathing trial (SBT) is the gold-standard bedside assessment to determine whether a patient can be safely liberated from mechanical ventilation. It evaluates the patient’s ability to breathe without significant ventilatory support, simulating post-extubation conditions. Timing includes usually after resolution of the underlying illness, hemodynamic stability, and adequate oxygenation/ventilation (lots of varying practice patterns). Prerequisites include FiO₂ ≤ 60% and PEEP ≤ 10 cm H₂O (general targets, may vary by patient), Hemodynamic stability (minimal/no vasopressors), Adequate mental status (can protect airway), and Manageable secretions.
Methods include Patient breathes through endotracheal tube with supplemental O₂ but no ventilator assistance, Pressure Support Ventilation (PSV): Most common in ICUs. Ventilator provides minimal support (PS 5-8 cm H₂O, PEEP 5 cm H₂O) to overcome endotracheal tube resistance, Continuous pressure applied but no pressure support, Multicenter RCT (≈1,000 patients) comparing pressure-support SBTs vs T-piece SBTs before extubation, and Pressure-support trials were associated with lower extubation failure rates than T-piece, especially in high-risk patients (older age, COPD, cardiac disease).
Rationale includes the endotracheal tube adds resistance; small pressure support helps approximate normal post-extubation conditions. Typical settings includes pS 5-8 cm H₂O, PEEP 5 cm H₂O, FiO₂ ≤ 60%. Provides a balance between realism and patient comfort. Clinical markers of success during an SBT HR < 120-140, SBP 90-180, minimal vasopressor needs and SpO₂ ≥ 90%, PaO₂/FiO₂ > 150-200. Tolerable work of breathing (no diaphoresis, accessory muscle use, paradoxical breathing).